These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32529753)

  • 1. Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study.
    Gutierrez-Mariscal FM; Cardelo MP; de la Cruz S; Alcala-Diaz JF; Roncero-Ramos I; Guler I; Vals-Delgado C; López-Moreno A; Luque RM; Delgado-Lista J; Perez-Martinez P; Yubero-Serrano EM; Lopez-Miranda J
    Mol Nutr Food Res; 2021 Jan; 65(1):e1901290. PubMed ID: 32529753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial.
    Gutierrez-Mariscal FM; Lopez-Moreno A; Torres-Peña JD; Gomez-Luna P; Arenas-de Larriva AP; Romero-Cabrera JL; Luque RM; Uribarri J; Perez-Martinez P; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
    Cardiovasc Diabetol; 2024 Oct; 23(1):361. PubMed ID: 39402581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
    de la Cruz-Ares S; Cardelo MP; Gutiérrez-Mariscal FM; Torres-Peña JD; García-Rios A; Katsiki N; Malagón MM; López-Miranda J; Pérez-Martínez P; Yubero-Serrano EM
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial.
    Gutierrez-Mariscal FM; Podadera-Herreros A; Alcalá-Diaz JF; Cardelo MP; Arenas-de Larriva AP; Cruz-Ares S; Torres-Peña JD; Luque RM; Perez-Martinez P; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
    Diabetes Metab; 2024 Jan; 50(1):101503. PubMed ID: 38097011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.
    Roncero-Ramos I; Gutierrez-Mariscal FM; Gomez-Delgado F; Villasanta-Gonzalez A; Torres-Peña JD; Cruz-Ares S; Rangel-Zuñiga OA; Luque RM; Ordovas JM; Delgado-Lista J; Perez-Martinez P; Camargo A; Alcalá-Diaz JF; Lopez-Miranda J
    Transl Res; 2021 Dec; 238():12-24. PubMed ID: 34298148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.
    Lopez-Moreno J; Quintana-Navarro GM; Camargo A; Jimenez-Lucena R; Delgado-Lista J; Marin C; Tinahones FJ; Striker GE; Roche HM; Perez-Martinez P; Lopez-Miranda J; Yubero-Serrano EM
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28233454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV study.
    Yubero-Serrano EM; Gutiérrez-Mariscal FM; Gómez-Luna P; Alcalá-Diaz JF; Pérez-Martinez P; López-Miranda J
    Clin Investig Arterioscler; 2023; 35(3):105-114. PubMed ID: 36184301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial.
    Podadera-Herreros A; Alcala-Diaz JF; Gutierrez-Mariscal FM; Jimenez-Torres J; Cruz-Ares S; Arenas-de Larriva AP; Cardelo MP; Torres-Peña JD; Luque RM; Ordovas JM; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
    Clin Nutr; 2022 Feb; 41(2):552-559. PubMed ID: 35030530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.
    Podadera-Herreros A; Arenas-de Larriva AP; Gutierrez-Mariscal FM; Alcala-Diaz JF; Ojeda-Rodriguez A; Rodriguez-Cantalejo F; Cardelo MP; Rodriguez-Cano D; Torres-Peña JD; Luque RM; Ordovas JM; Perez-Martinez P; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
    Nutr Diabetes; 2024 May; 14(1):27. PubMed ID: 38755195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.
    Roncero-Ramos I; Alcala-Diaz JF; Rangel-Zuñiga OA; Gomez-Delgado F; Jimenez-Lucena R; García-Rios A; Vals-Delgado C; Romero-Baldonado C; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
    Clin Nutr; 2020 Feb; 39(2):492-500. PubMed ID: 30852029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study.
    Gutierrez-Mariscal FM; Alcalá-Diaz JF; Quintana-Navarro GM; de la Cruz-Ares S; Torres-Peña JD; Cardelo MP; Arenas-Larriva AP; Malagón MM; Romero-Cabrera JL; Ordovás JM; Pérez-Martínez P; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
    Eur J Nutr; 2023 Jun; 62(4):1903-1913. PubMed ID: 36869909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial.
    Yubero-Serrano EM; Fernandez-Gandara C; Garcia-Rios A; Rangel-Zuñiga OA; Gutierrez-Mariscal FM; Torres-Peña JD; Marin C; Lopez-Moreno J; Castaño JP; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Lopez-Miranda J
    PLoS Med; 2020 Sep; 17(9):e1003282. PubMed ID: 32903262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does dietary fat affect advanced glycation end products and their receptors? A systematic review of clinical trials.
    Mendes NP; Ribeiro PVM; Alfenas RCG
    Nutr Rev; 2022 Feb; 80(3):598-612. PubMed ID: 34871448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediterranean Diet, Glucose Homeostasis, and Inflammasome Genetic Variants: The CORDIOPREV Study.
    Roncero-Ramos I; Rangel-Zuñiga OA; Lopez-Moreno J; Alcala-Diaz JF; Perez-Martinez P; Jimenez-Lucena R; Castaño JP; Roche HM; Delgado-Lista J; Ordovas JM; Camargo A; Lopez-Miranda J
    Mol Nutr Food Res; 2018 May; 62(9):e1700960. PubMed ID: 29573224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
    Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
    Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Remission Is Modulated by Branched Chain Amino Acids According to the Diet Consumed: From the CORDIOPREV Study.
    Cardelo MP; Alcala-Diaz JF; Gutierrez-Mariscal FM; Lopez-Moreno J; Villasanta-Gonzalez A; Arenas-de Larriva AP; Cruz-Ares S; Delgado-Lista J; Rodriguez-Cantalejo F; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
    Mol Nutr Food Res; 2022 Feb; 66(4):e2100652. PubMed ID: 34863046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.
    de Courten B; de Courten MP; Soldatos G; Dougherty SL; Straznicky N; Schlaich M; Sourris KC; Chand V; Scheijen JL; Kingwell BA; Cooper ME; Schalkwijk CG; Walker KZ; Forbes JM
    Am J Clin Nutr; 2016 Jun; 103(6):1426-33. PubMed ID: 27030534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.
    Ojeda-Rodriguez A; Rangel-Zuñiga OA; Arenas-de Larriva AP; Gutierrez-Mariscal FM; Torres-Peña JD; Romero-Cabrera JL; Podadera-Herreros A; García-Fernandez H; Porras-Pérez E; Luque RM; Kales SN; Perez-Martinez P; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
    Cardiovasc Diabetol; 2024 Mar; 23(1):98. PubMed ID: 38493287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
    Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
    Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
    Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.